comparemela.com

Latest Breaking News On - Michaelj morris - Page 1 : comparemela.com

JNJ-6420 Elicits Responses in mCRPC, But Safety Concerns Arise

A novel radioligand therapy, JNJ-6420, demonstrates potential in treating mCRPCr, delivering sustained responses following only 1-2 doses.

Michaelj-morris
Memorial-sloan-kettering-cancer-center
Morris
Division-of-solid-tumor-oncology
Solid-tumor-oncology

ASCO 2024: A Phase 1 Study of JNJ-69086420 (JNJ-6420), an Actinium-225 (225Ac)-Labeled Antibody Targeting Human Kallikrein 2, for mCRPC

ASCO 2024, prostate cancer, metastatic castration-resistant prostate cancer (mCRPC), JNJ-69086420 (JNJ-6420), Actinium-225 (225Ac), Targeting Human Kallikrein 2, JNJ-6420 adverse events.

Memorial-sloan-kettering-cancer-center
New-york
United-states
Chicago
Illinois
Georgia
American
Michaelj-morris
Michael-morris
Zachary-klaassen
Twitter
American-society-of-clinical-oncology

Naheed Bardai, Rochelle Wempe, Michael Morris appointed to Saskatchewan courts

Bardai was appointed to the Court of Appeal, while Wempe and Morris to the Court of King's Bench

Saskatchewan
Manitoba
Canada
Ottawa
Ontario
France
French
Naheed-bardai
Nelligan-obrien-payne
Rochelle-wempe
Arif-virani
Michaelj-morris

BioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

Collaboration with the US Department of Defense’s largest military health organization underway .

Texas
United-states
Colorado
Americans
Maria-zannes
David-elzi
Michaelj-morris
Laboratory-developed-test
Facebook
Company-annual-report-on-form
Department-of-defense
University-of-colorado-department-surgery

Canada's AG Announces Saskatchewan Judicial Appointments

Canada's AG Announces Saskatchewan Judicial Appointments
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Ottawa
Ontario
Canada
Australia
Melbourne
Victoria
Saskatoon
Saskatchewan
France
Manitoba
French
Canadian

vimarsana © 2020. All Rights Reserved.